Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bacteremic biliary tract infection without anaerobic bacteremia

@IDDoc_Mittal @JamesWilsonDO1 @Abx_doc @dralicehan @DrEmilyMcD @DrToddLee @BradSpellberg @ABsteward @IDstewardship @Cortes_Penfield @JonathanRyderMD Thanks for sharing https://t.co/lZOxsIQSqW

A new intern asked if amp-sulbactam was a good choice for acute cholangitis and I said no. Not only is GNR resistance high in our area, but a new study suggests definitive therapy w/ anaerobic coverage does not improve outcomes absent anaerobic bacteremia.

Biliary tract infections. If you don't isolate anaerobes then you don't need anaerobic cover. https://t.co/P0XfU07GCB

Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bact... https://t.co/zufLnZr78A #bmcinfectdis